-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Fusion Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q1 2024.
- Fusion Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$33.7M, a 38.6% decline year-over-year.
- Fusion Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$104M, a 13.4% decline year-over-year.
- Fusion Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$94.9M, a 8.32% decline from 2022.
- Fusion Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$87.6M, a 8.1% decline from 2021.
- Fusion Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$81M, a 3.47% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)